ReviewLasers in medical science2026
Research advances in the pathogenesis and photodynamic therapy of pathological scars.
Review in Lasers in medical science, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
This review summarizes recent advances in the pathogenesis of pathological scars, including hypertrophic scars and keloids, and their photodynamic therapy (PDT). The formation of pathological scars involves fibroblast dysfunction, imbalanced ECM metabolism, chronic inflammation, aberrant activation of multiple signaling pathways (e.g., TGF-β/Smad, JAK/STAT, PI3K/Akt/mTOR), epigenetic regulation, and biomechanical factors, against a background of genetic susceptibility. As a minimally invasive and targeted therapy, PDT acts through the generation of reactive oxygen species (ROS) upon light activation of photosensitizers, leading to fibroblast death, suppression of collagen synthesis, interruption of key signaling pathways, and modulation of immune responses and angiogenesis, thereby effectively improving scars. Recent developments in novel photosensitizers and nanotechnology-based delivery systems have significantly enhanced the penetration and efficacy of PDT, offering new directions for its precise clinical application.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.